Patents by Inventor Jamie Snider

Jamie Snider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220062242
    Abstract: Methods of inhibiting mutant EGFR and methods of treating a subject afflicted with a lung cancer having a mutant EGFR, having for example a C797 mutation, are described. The methods comprise administering to a cell or a subject in need thereof a therapeutically effective amount of a compound selected from 3-(1,3-benzoxazol-2-yl)-7-(diethylamino)-2H-chromen-2-one and a structurally related analog thereof; midostaurin; and AZD7622 and a structurally related analog thereof; and mixtures thereof. Compositions and combinations comprising the compounds of the disclosure as well as uses are also provided.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Inventors: Igor Stagljar, Jamie Snider, Punit Saraon
  • Patent number: 11123330
    Abstract: Methods of inhibiting mutant EGFR and methods of treating a subject afflicted with a lung cancer having a mutant EGFR, having for example a C797 mutation, are described. The methods comprise administering to a cell or a subject in need thereof a therapeutically effective amount of a compound selected from 3-(1,3-benzoxazol-2-yl)-7-(diethylamino)-2H-chromen-2-one and a structurally related analog thereof; midostaurin; and AZD7622 and a structurally related analog thereof; and mixtures thereof. Compositions and combinations comprising the compounds of the disclosure as well as uses are also provided.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 21, 2021
    Assignee: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Igor Stagljar, Jamie Snider, Punit Saraon
  • Publication number: 20190091205
    Abstract: Methods of inhibiting mutant EGFR and methods of treating a subject afflicted with a lung cancer having a mutant EGFR, having for example a C797 mutation, are described. The methods comprise administering to a cell or a subject in need thereof a therapeutically effective amount of a compound selected from 3-(1,3-benzoxazol-2-yl)-7-(diethylamino)-2H-chromen-2-one and a structurally related analog thereof; midostaurin; and AZD7622 and a structurally related analog thereof; and mixtures thereof. Compositions and combinations comprising the compounds of the disclosure as well as uses are also provided.
    Type: Application
    Filed: September 28, 2018
    Publication date: March 28, 2019
    Inventors: Igor Stagljar, Jamie Snider, Punit Saraon
  • Patent number: 8843882
    Abstract: A system and method capable of summarizing data for all of a software company's engineers, repos (projects) and the entire organization so the executives and managers of the organization can make better decisions. The system is configured to fetch and mine data related to the end-user's organization, projects, people, source code and source code metadata and use proprietary algorithms to calculate various scores such as Velocity, Churn and Skill. The end-user is able to see the various scores, including a Master Score, for various contexts such as the Organization, repos (projects) or individuals (engineers). The score provides a CTO or VP of Engineering, for instance, with a quick health status that would otherwise be unknown or very time-consuming to obtain.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: September 23, 2014
    Assignee: Codalytics, Inc.
    Inventors: Bardia Dejban, Jamie Snider, Gary Rudolph